Cardiomyopathy Precision Medicine Symposium

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous coronary intervention (PCI), a procedure to open blocked arteries, compared with those who took medications alone but did not undergo PCI, according to research presented at the American College

April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were significantly higher among patients whose procedures were guided by intravascular ultrasound (IVUS) alongside angiography compared with those whose procedures were guided by angiography alone, in a study presented at the American College of Cardiology’s Annual Scientific Session.

April 10, 2024 — The American Medical Association (AMA) released informal 

April 10, 2024 — A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients.

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as the organization’s first non-physician president. She will serve a one-year term representing over 56,000 cardiovascular care team members around the world and leading the cardiovascular organization in its mission to transform cardiovascular care and improve heart health for all.

April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with 

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes did not meet its primary endpoint, but a preplanned subgroup analysis found a statistically significant effect of treatment in patients who were not taking 

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with evidence of improvements in symptoms and exercise capacity among people with nonobstructive hypertrophic cardiomyopathy (HCM), according to results of a 12-week phase 2 trial presented at the American College of Cardiolo

April 10, 2024 — An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace,1 a journal of the European Society of Cardiology (ESC), and presented at EHRA 2024, a scientific congress of the ESC2 which was

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now